Shavit Capital leads Series A round for Mapi

Israeli pharmaceutical company Mapi Pharma Ltd has secured $10 million in Series A funding. Shavit Capital led the round.

27 May 2015•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.